{"id":3864,"date":"2016-08-08T08:53:24","date_gmt":"2016-08-08T12:53:24","guid":{"rendered":"https:\/\/medicarereport.org\/?p=3864"},"modified":"2016-08-08T08:53:24","modified_gmt":"2016-08-08T12:53:24","slug":"a-key-trial-for-a-bristol-myers-cancer-drug-fails-in-a-major-surprise","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=3864","title":{"rendered":"A key trial for a Bristol-Myers cancer drug fails in a \u2018major surprise\u2019"},"content":{"rendered":"<p>(By Ed Silverman for ST<em>A<\/em>T)<\/p>\n<p><span class=\"big-cap\">I<\/span>n a stunning setback for Bristol-Myers Squibb, its blockbuster Opdivo medicine failed to meet the primary endpoint in an important, late-stage study involving patients with newly diagnosed non-small cell lung cancer. The news sent Bristol-Myers stock plunging 17 percent in early trading, while giving a boost to Merck, its biggest rival among companies with so-called checkpoint inhibitor treatments. <a href=\"https:\/\/www.statnews.com\/pharmalot\/2016\/08\/05\/bristol-myers-opdivo-fails-lung-cancer\/\" target=\"_blank\">Continue reading article here&#8230;&#8230;.<\/a><\/p>\n<pre><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Ed Silverman for STAT) In a stunning setback for Bristol-Myers Squibb, its blockbuster Opdivo medicine failed to meet the<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"class_list":["post-3864","post","type-post","status-publish","format-standard","hentry","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/3864","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3864"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/3864\/revisions"}],"predecessor-version":[{"id":3865,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/3864\/revisions\/3865"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3864"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3864"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3864"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}